Company patents

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. demonstrates a strong and growing focus on Medical Diagnostics & Surgery, which constitutes 76.8% of its portfolio and saw a significant 50.0% YoY growth in 2025, with 11 patents so far in 2026 despite a partial year. Surprisingly, while Drug Delivery Devices remains a substantial area (44.6% of portfolio), its growth has plateaued, showing 0.0% YoY change in both 2025 and 2026, indicating a potential shift in R&D priorities towards surgical innovations over pure drug delivery mechanisms.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

56 US filings (since 2023) · 4 categories · 3 themes

Patents

Page 1 of 4